Medicare Enrolled
Dr. Adam Shapira, M.D.
Cardiovascular Disease · Dallas, TX
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shapira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shapira? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shapira
Dr. Adam Shapira is a cardiovascular disease in Dallas, TX, with 18 years in practice. Based on federal Medicare data, Dr. Shapira performed 4,597 Medicare services across 3,342 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shapira received a total of $9,343 from 33 pharmaceutical and/or device companies across 183 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shapira is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 20% volume in TX$ $9,343 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,597
Medicare services
Top 20% in TX for cardiovascular disease
3,342
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~255 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,152 | $88 | $190 |
| Electrocardiogram (EKG), 12-lead | 574 | $10 | $92 |
| Remote pacemaker/defibrillator monitoring, 90 days | 508 | $16 | $60 |
| Remote pacemaker monitoring, 90 days | 379 | $22 | $95 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 325 | $15 | $95 |
| Office visit, established patient (20-29 min) | 263 | $62 | $135 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 131 | $26 | $95 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 130 | $25 | $95 |
| New patient office visit (45-59 min) | 119 | $114 | $245 |
| Programming of dual lead pacemaker system | 94 | $27 | $118 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 88 | $207 | $700 |
| New patient office visit, complex (60-74 min) | 84 | $157 | $297 |
| Office visit, established patient, complex (40-54 min) | 73 | $124 | $265 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 65 | $676 | $8,081 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 64 | $18 | $68 |
| 3d radiographic procedure with computerized image postprocessing | 60 | $29 | $96 |
| Programming of heart rhythm stimulation after drug infusion | 58 | $61 | $537 |
| Prothrombin time test (blood clotting) | 54 | $4 | $29 |
| Evaluation of cardiac rhythm monitor system | 50 | $13 | $50 |
| Hospital follow-up visit, moderate complexity | 44 | $53 | $133 |
| Programming of multiple lead implantable defibrillator system | 36 | $45 | $162 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 32 | $196 | $500 |
| Programming of multiple lead pacemaker system | 28 | $29 | $137 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 27 | $366 | $3,350 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 26 | $230 | $3,848 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 24 | $230 | $3,848 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $15 | $132 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 15 | $346 | $2,224 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $615 | $8,081 |
| Initial hospital admission, moderate complexity | 14 | $100 | $249 |
| Removal and replacement of multiple lead defibrillator | 13 | $303 | $1,090 |
| External shock to heart to regulate heart beat | 12 | $82 | $670 |
| Removal and replacement of multiple lead permanent pacemaker | 11 | $267 | $1,018 |
| Destruction of heart conduction tissue to create heart block | 11 | $436 | $3,848 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
40.5% high complexity
0.4% medium
59.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,343
Total received (2018-2024)
Avg $1,335/year across 7 years
Top 34% in TX for cardiovascular disease
33
Companies
183
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,709 (82.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,634 (17.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$712
2023$1,962
2022$1,664
2021$365
2020$498
2019$2,750
2018$1,392
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$4,351
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,735
Medtronic, Inc.
$644
CARDIVA MEDICAL, INC.
$329
BOSTON SCIENTIFIC CORPORATION
$261
Biosense Webster, Inc.
$206
Boston Scientific Corporation
$176
ATRICURE, INC.
$172
Lundbeck LLC
$153
Philips Electronics North America Corporation
$151
SANOFI-AVENTIS U.S. LLC
$132
AtriCure, Inc.
$132
Janssen Pharmaceuticals, Inc
$125
AltaThera Pharmaceuticals LLC
$113
Philips North America LLC
$97
Bardy Diagnostics, Inc.
$70
Amgen Inc.
$67
Davol Inc.
$48
Gilead Sciences, Inc.
$44
Edwards Lifesciences Corporation
$43
E.R. Squibb & Sons, L.L.C.
$40
Baxter Healthcare
$36
Impulse Dynamics (USA) Inc.
$33
ARALEZ PHARMACEUTICALS US INC.
$27
GE Healthcare
$26
AngioDynamics, Inc.
$23
AstraZeneca Pharmaceuticals LP
$21
CORDIS US CORP.
$18
Stryker Corporation
$16
Aziyo Biologics, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Amarin Pharma Inc.
$14
Medtronic Vascular, Inc.
$12
Top 3 companies account for 72.0% of total payments
Associated products mentioned in payments ›
(5050) Ext Holter · (5050) Extended Holter · (5054) Geneva · (7999) SRC Undivided · (CK7) Extended Holter · AMPERE · ARCTIC FRONT ADVANCE · ARISTA AH FLEXITIP · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE SYNERGY ABLATION SYSTEM · AVEIR · Advisor Catheter · Allure Quadra RF CRT Pacemaker · Anthem CRT Pacemaker · Assurity Pacemaker · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CONFIRM RX · CRT-Ds · Cardiva VASCADE MVP VVCS 6-12F · Carnation Ambulatory Monitor · Claria MRI · Confirm Rx · Corlanor · Durata Defibrillation ICD Lead · ECM Patch · ELIQUIS · ENSITE · ENSITE PRECISION · EP Recording Systems · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · Ensite Cardiac Mapping System · FlexAbility Ablation Catheter · Fortify Assura · Hillrom - Cardiac Ambulatory Monitor · Irrigated Ablation Catheters · JARDIANCE · JOT DX · LOKELMA · LifeVest · MERLIN@HOME · MULTAQ · MYNX CONTROL · Merlin Connectivity and Remote · N/A · NA · NORTHERA · OPTIMIZER · Pacemakers · Perclose ProGlide suture mediated closure system · Pouch · QUADRA ALLURE MP · QUADRA ASSURA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · Repatha · SENSOR ENABLED · Sotalol Hydrochloride · TACTICATH · TACTICATH ABLATION CATHETER · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TactiCath Quartz CFA Catheter · Vascepa · WATCHMAN · WATCHMAN Access System · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $203 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
301
Per 100K population
11.6
County median income
$74,149
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER UPTOWN
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shapira is a electrophysiology & remote specialist, with above-average Medicare volume (top 20% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shapira experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shapira performed 1,152 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shapira receive payments from pharmaceutical companies?
Yes. Dr. Shapira received a total of $9,343 from 33 companies across 183 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shapira's costs compare to other cardiovascular diseases in Dallas?
Dr. Shapira's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shapira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Dallas
Browse cardiovascular diseases in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology